BiomX (PHGE) Minority Interest (2018 - 2026)
BiomX's (PHGE) quarterly Minority Interest came in at $6.8 million in Q2 2026, down 89.68% quarter-over-quarter from $65.5 million in Q3 2019.
Analysis
BiomX (PHGE) Minority Interest (2018 - 2026) Analysis & Trends
BiomX has disclosed Minority Interest across 3 years of filings, most recently posting $6.8 million for Q2 2026.
- In Q2 2026, Minority Interest changed N/A year-over-year to $6.8 million; the TTM figure through Jun 2026 stood at $6.8 million (changed N/A YoY), while the FY2019 annual figure was $65.7 million, changed N/A from the prior year.
- Minority Interest came in at $6.8 million for Q2 2026 at BiomX, down from $65.5 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $6.8 million in Q2 2026 to a low of $6.8 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | BiomX | 17.33 Mn | 16.75 Mn | 97,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.76 Mn |
| Sep 30, 2019 | 65.46 Mn |
| Jun 30, 2019 | 65.75 Mn |
| Mar 31, 2019 | 65.69 Mn |
| Dec 31, 2018 | 65.41 Mn |